Literature DB >> 33314404

Genetic causes of haemophilia in women and girls.

Connie H Miller1, Christopher J Bean1.   

Abstract

Women and girls reported as "haemophilic females" may have complex genetic causes for their haemophilia phenotype. In addition, women and girls may have excessive bleeding requiring treatment simply because they are heterozygous for haemophilia alleles. While severe and moderate haemophilia are rare in females, 16% of patients with mild haemophilia A and almost one-quarter of those with mild haemophilia B seen in U.S. haemophilia treatment centres are women and girls. A phenotypic female with a low level of factor VIII or factor IX may be classified into one of the following categories of causality: homozygosity (two identical haemophilia alleles), compound heterozygosity (two different haemophilia alleles), hemizygosity (one haemophilia allele and no normal allele), heterozygosity (one haemophilia allele and one normal allele), genetic causes other than haemophilia and non-genetic causes. Studies required for classification may include coagulation parameters, F8 or F9 sequencing, F8 inversion testing, multiplex ligation-dependent probe amplification, karyotyping and X chromosome inactivation studies performed on the patient and parents. Women and girls who are homozygous, compound heterozygous or hemizygous clearly have haemophilia, as they do not have a normal allele. Heterozygous women and girls with factor levels below the haemostatic range also meet the definitions used for haemophilia treatment. © Published 2020. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  factor IX; factor VIII; haemophilia A; haemophilia B

Mesh:

Substances:

Year:  2020        PMID: 33314404      PMCID: PMC8132474          DOI: 10.1111/hae.14186

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.263


  103 in total

1.  Somatic mosaicism and compound heterozygosity in female hemophilia B.

Authors:  J M Costa; D Vidaud; I Laurendeau; M Vidaud; E Fressinaud; J P Moisan; A David; D Meyer; J M Lavergne
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

2.  Delayed diagnosis of congenital factor IX deficiency (Christmas disease) in a girl with Turner's Syndrome.

Authors:  G Kelsey; P Monagle; C Barnes
Journal:  Clin Lab Haematol       Date:  2006-10

3.  Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.

Authors:  Peter W Collins; Elizabeth Chalmers; Daniel Hart; Ian Jennings; Ri Liesner; Savita Rangarajan; Kate Talks; Michael Williams; Charles R M Hay
Journal:  Br J Haematol       Date:  2013-07-25       Impact factor: 6.998

Review 4.  Definitions in hemophilia: resolved and unresolved issues.

Authors:  Victor S Blanchette; Alok Srivastava
Journal:  Semin Thromb Hemost       Date:  2015-10-19       Impact factor: 4.180

5.  Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.

Authors:  Anna Olsson; Margareta Hellgren; Erik Berntorp; Rolf Ljung; Fariba Baghaei
Journal:  Blood Coagul Fibrinolysis       Date:  2014-07       Impact factor: 1.276

6.  Methods for the detection of haemophilia carriers: a memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

7.  Deletion of the factor IX gene as a result of translocation t(X;1) in a girl affected by haemophilia B.

Authors:  A C Krepischi-Santos; J D Carneiro; M Svartman; I Bendit; V Odone-Filho; A M Vianna-Morgante
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

8.  A de novo translocation 46,X,t(X;15) causing haemophilia B in a girl: a case report.

Authors:  W Schröder; M Poetsch; H Gazda; W Werner; T Reichelt; W Knoll; R Rokicka-Milewska; B Zieleniewska; F H Herrmann
Journal:  Br J Haematol       Date:  1998-03       Impact factor: 6.998

9.  Extreme skewing of X-inactivation: Rethinking severe haemophilia in women and girls.

Authors:  Jane A Mason; Jeremy D Robertson
Journal:  Haemophilia       Date:  2019-04-17       Impact factor: 4.287

10.  Molecular mechanisms underlying hemophilia A phenotype in seven females.

Authors:  A Pavlova; H Brondke; J Müsebeck; H Pollmann; A Srivastava; J Oldenburg
Journal:  J Thromb Haemost       Date:  2009-03-19       Impact factor: 5.824

View more
  5 in total

1.  Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.

Authors:  Connie H Miller; J Michael Soucie; Vanessa R Byams; Amanda B Payne; Robert F Sidonio; Tyler W Buckner; Christopher J Bean
Journal:  Haemophilia       Date:  2021-09-04       Impact factor: 4.263

2.  Investigation of the Bleeding Tendency in Sudanese Female Carriers of Hemophilia B.

Authors:  Ismail Ali Abdallah Abker; Salaheldein G Elzaki; Salih Abdelgader Elmahdi; Jowaria Eltayeb Tayrab; Samia Mahdi Ahmed; Eltayeb Tayrab
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

3.  X-linked adrenoleukodystrophy caused by maternal ABCD1 mutation and paternal X chromosome inactivation.

Authors:  Zhen Li; Guangrui Lai
Journal:  Exp Ther Med       Date:  2022-07-12       Impact factor: 2.751

4.  Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues.

Authors:  Angela C Weyand; Robert F Sidonio; Michelle Sholzberg
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263

5.  Potential Biochemical Markers and Radiomorphometric Indices as Predictors of Reduced Bone Mass in Patients with Congenital Hemophilia.

Authors:  Sylwia Czajkowska; Joanna Rupa-Matysek; Ewelina Wojtasińska; Kacper Nijakowski; Lidia Gil; Anna Surdacka; Tomasz Kulczyk
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.